The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AVITA THERAPEUTICS INC SPONSORED ADS 05380C102 28,148 921,663 SH   SOLE   194,082 0 727,581
AXONICS MODULATION TECHNOLOG COM 05465P101 15,040 428,359 SH   SOLE   158,307 0 270,052
BIOHAVEN PHARMACEUTICAL HOLD COM G11196105 8,983 122,865 SH   SOLE   50,472 0 72,393
MICROSOFT CORP COM 594918104 2,857 14,039 SH   SOLE   5,904 0 8,135
NICE LTD - SPON ADR SPONSORED ADR 653656108 8,262 43,657 SH   SOLE   7,813 0 35,844
ONCOCYTE CORP COM 68235C107 5,697 2,982,557 SH   SOLE   888,360 0 2,094,197
PROFOUND MEDICAL CORP COM NEW 74319B502 2,970 175,301 SH   SOLE   126,196 0 49,105
TAKEDA PHARMACEUTIC-SP ADR SPONSORED ADS 874060205 461 25,723 SH   SOLE   600 0 25,123
WIX.COM LTD SHS M98068105 15,983 62,379 SH   SOLE   10,834 0 51,545